Market Overview
Global Bare-metal Coronary Stents market size was valued at USD 2,860 million in 2024. The market is projected to reach USD 3,987 million by 2031, exhibiting a CAGR of 5.0% during the forecast period.
A bare-metal stent is a device made of thin, uncoated metal wire formed into a mesh-like tube. The first stents licensed for use in cardiac arteries were bare metal, often 316L stainless steel. More recent second-generation bare-metal stents have been made of cobalt chromium alloy.
USD 2,860 million in 2024
USD 3,987 million by 2031
CAGR of 5.0%
The Bare-metal Coronary Stents market is segmented based on type into diameters that cater to varying anatomical needs in percutaneous coronary interventions. These segments reflect the clinical requirements for precise vessel support, with smaller diameters being more prevalent in standard procedures for coronary artery disease management. The choice of diameter influences procedural success rates and long-term patency, driving adoption in diverse patient populations.
Stent Diameter ≤4mm
Stent Diameter >4mm
By Application
The market is segmented based on application into various healthcare facilities where bare-metal coronary stents are deployed. This segmentation highlights the critical role of these stents in interventional cardiology, supporting rapid revascularization in acute settings and elective treatments. Hospitals, with their advanced infrastructure, dominate due to the volume of angioplasty procedures performed annually worldwide.
ASCs (Ambulatory Surgical Centers)
Hospitals
Cardiology Centers
Others
Portable Neuromonitoring Device Market
Our Key Players
Boston Scientific Corporation (U.S.)
Abbott Laboratories (U.S.)
Medtronic plc (Ireland)
Terumo Corporation (Japan)
MicroPort Scientific Corporation (China)
B. Braun Melsungen AG (Germany)
https://www.24lifesciences.com/dow
https://www.24lifesciences.com
